Chronic pancreatitis is now recognized as a complex fibroinflammatory disorder involving genetic, environmental, and metabolic factors.

Eliana Merle Barclays Bank PLC, Research Division. Great. Good afternoon, everyone. I'm Ellie Merle, one of the biotech analysts here at Barclays. Very happy to have Ionis here wi ...

CORE-TIMI 72a and CORE2-TIMI 72b trials found that olezarsen significantly reduced triglyceride levels at 6 months, as well as decreased the incidence of acute pancreatitis.

PHILADELPHIA — The investigational drug navenibart reduced attacks of hereditary angioedema by an average 91% over 1 year with only twice-yearly dosing and no serious adverse effects or safety signals ...

A pancreatitis-friendly diet includes high-energy, high-protein, calcium-rich, and antioxidant foods. Avoid high-fat, high-fiber, or anti-nutrient foods that may worsen your symptoms or block nutrient ...

Ionis Pharmaceuticals received FDA Priority Review for its supplemental New Drug Application for olezarsen, targeting severe hypertriglyceridemia and reduction of acute pancreatitis risk. The company ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

Billy is a Senior Features Author for Collider. Having written over 300 articles in just over a year, Billy regularly covers the biggest TV shows and films releasing while also analysing some of the ...